He founded EXEL and I don't believe he's going to settle for a valuation of less than $3B. He sold ANDS for a 250% premium less than 2 years ago and he knows what EXEL (COMETRIQ) is worth. The total MV(of ANDS) was only about $300M Roche was glad to get it for that low a premium, EXEL would fetch a much higher premium at this current level.
All this speculation may just be due to a planted story by the HF shorts who are trying to add to their shorts before the ER is released in the 2nd week of February. The only way I trust the eventual buyout is if the stock trades above the the 5.30-5.50 congestion on volume.
The key missing ingredient is volume. Makes me laugh...they drop it 6% on 2X average volume - bounce it back up 6% on normal volume - then "paint it up" 2% AH last Friday based on 300 shares. Who are they fooling?
I have followed Stellios for a while now. I remembered buying Exel when it was rejected by BMY. I purchased at $2.99 and have accumulated a sizeable position after he didn sell out when Icahn left . Today I am understanding how people like Stellios P, sees things. They see things differently and act accordingly. These people like him and Icahn are good at what they do. I am willing to bet that Icahn may get back in anytime. This would just send this stock ripping. Lets hope soon.